Argitalpenak (26) Sara Zalba Oteiza argitalpenak

2024

  1. Foxp3 inhibitory peptide encapsulated in a novel CD25-targeted nanoliposome promotes efficient tumor regression in mice

    Acta Pharmacologica Sinica

  2. Lipid-based nanosystems: the next generation of cancer immune therapy

    Journal of Hematology and Oncology, Vol. 17, Núm. 1

2023

  1. Assessment of Clinical Response to V937 Oncolytic Virus After Intravenous or Intratumoral Administration Using Physiologically-Based Modeling

    Clinical Pharmacology and Therapeutics, Vol. 114, Núm. 3, pp. 623-632

2022

  1. Stealth nanoparticles in oncology: Facing the PEG dilemma

    Journal of Controlled Release, Vol. 351, pp. 22-36

2021

  1. Drug transport kinetics of intravascular triggered drug delivery systems

    Communications Biology, Vol. 4, Núm. 1

  2. Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model

    Journal of Nanobiotechnology, Vol. 19, Núm. 1

  3. Mechanistic Modeling of a Novel Oncolytic Virus, V937, to Describe Viral Kinetic and Dynamic Processes Following Intratumoral and Intravenous Administration

    Frontiers in Pharmacology, Vol. 12

  4. Modulation of intratumoural myeloid cells, the hallmark of the anti-tumour efficacy induced by a triple combination: tumour-associated peptide, TLR-3 ligand and α-PD-1

    British Journal of Cancer, Vol. 124, Núm. 7, pp. 1275-1285

  5. Semi-mechanistic model for the antitumor response of a combination cocktail of immuno-modulators in non-inflamed (Cold) tumors

    Cancers, Vol. 13, Núm. 20

2020

  1. Quantification of pharmacokinetic profiles of pd-1/pd-l1 antibodies by validated elisas

    Pharmaceutics, Vol. 12, Núm. 6, pp. 1-16

  2. Sensitization of drug resistant sarcoma tumors by membrane modulation: Via short chain sphingolipid-containing nanoparticles

    Nanoscale, Vol. 12, Núm. 32, pp. 16967-16979

2019

  1. A new immune-nanoplatform for promoting adaptive antitumor immune response

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 17, pp. 13-25

  2. Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma response

    International Journal of Nanomedicine, Vol. 14, pp. 2069-2089

2018

  1. Immunoliposomes in clinical oncology: State of the art and future perspectives

    Journal of Controlled Release, Vol. 275, pp. 162-176

2017

  1. Cell membrane modulation as adjuvant in cancer therapy

    Cancer Treatment Reviews, Vol. 52, pp. 48-57

2016

  1. EGF-liposomes promote efficient EGFR targeting in xenograft colocarcinoma model

    Nanomedicine, Vol. 11, Núm. 5, pp. 465-477

  2. EGFR targeted thermosensitive liposomes: A novel multifunctional platform for simultaneous tumor targeted and stimulus responsive drug delivery

    Colloids and Surfaces B: Biointerfaces, Vol. 146, pp. 657-669

  3. Targeting melanoma with immunoliposomes coupled to anti-MAGEAI TCR-like single-chain antibody

    International Journal of Nanomedicine, Vol. 11, pp. 955-975

2015

  1. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer

    Journal of Controlled Release, Vol. 210, pp. 26-38

2013

  1. Efficient serum-resistant lipopolyplexes targeted to the folate receptor

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 83, Núm. 3, pp. 358-363